Wigginton Jon Marc 4
4 · MACROGENICS INC · Filed Nov 21, 2017
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Wigginton Jon Marc
Senior VP, Clinical Dev.
Transactions
- Sale
Common Stock
2017-11-21$20.00/sh−5,000$100,000→ 30,000 total - Exercise/Conversion
Common Stock
2017-11-21$4.70/sh+5,000$23,500→ 35,000 total - Exercise/Conversion
Employee stock option (right to buy)
2017-11-21−5,000→ 50,448 totalExercise: $4.70From: 2014-01-18Exp: 2023-07-18→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
- [F2]This transaction was executed in multiple trades at prices ranging from $20 to $20.03
- [F3]This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18.